• Nirsevimab for the prevention of RSV disease in all infants Cite CITE Title : Nirsevimab for the prevention of RSV disease in all infants Personal Author(s) : Felter, C. Corporate Authors(s) : Sanofi AstraZeneca Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting Respiratory Syncytial Virus (RSV) Vaccine URL : https://stacks.cdc.gov/view/cdc/118595 Felter, C. (2022). Nirsevimab for the prevention of RSV disease in all infants. 202208(80805). Felter, C. "Nirsevimab for the prevention of RSV disease in all infants" 202208, no. 80805 (2022) Felter, C. "Nirsevimab for the prevention of RSV disease in all infants" vol. 202208, no. 80805, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 1.43 MB] Personal Author: Felter, C. June 23, 2022 | ACIP meeting Respiratory Syncytial Virus (RSV) Vaccine Description: slides-2022-06-22-23/05-RSV-Felter-508.pdf File Type: [PDF - 1.43 MB] File Type: [PDF - 1.43 MB] Respiratory Syncytial Virus (RSV) seasonality in the United States and the burden of RSV in children Cite CITE Title : Respiratory Syncytial Virus (RSV) seasonality in the United States and the burden of RSV in children Personal Author(s) : McMorrow, Meredith Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Respiratory Viruses Branch. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting Respiratory Syncytial Virus (RSV) Vaccine URL : https://stacks.cdc.gov/view/cdc/118593 McMorrow, Meredith (2022). Respiratory Syncytial Virus (RSV) seasonality in the United States and the burden of RSV in children. 202208(80803). McMorrow, Meredith "Respiratory Syncytial Virus (RSV) seasonality in the United States and the burden of RSV in children" 202208, no. 80803 (2022) McMorrow, Meredith "Respiratory Syncytial Virus (RSV) seasonality in the United States and the burden of RSV in children" vol. 202208, no. 80803, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 888.17 KB] Personal Author: McMorrow, Meredith June 23, 2022 | ACIP meeting Respiratory Syncytial Virus (RSV) Vaccine Description: 03-RSV-McMorrow-508.pdf File Type: [PDF - 888.17 KB] File Type: [PDF - 888.17 KB] Monkeypox update Cite CITE Title : Monkeypox update Personal Author(s) : Petersen, Brett W. Corporate Authors(s) : National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. Poxvirus and Rabies Branch. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting Monkeypox informational session URL : https://stacks.cdc.gov/view/cdc/118598 Petersen, Brett W. (2022). Monkeypox update. 202208(81002). Petersen, Brett W. "Monkeypox update" 202208, no. 81002 (2022) Petersen, Brett W. "Monkeypox update" vol. 202208, no. 81002, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 691.02 KB] Personal Author: Petersen, Brett W. June 23, 2022 | ACIP meeting Monkeypox informational session Description: 02-MPX-Petersen-508.pdf File Type: [PDF - 691.02 KB] File Type: [PDF - 691.02 KB] Situational awareness : Monkeypox outbreak—United States, June 2022 Cite CITE Title : Situational awareness : Monkeypox outbreak—United States, June 2022 Personal Author(s) : Rao, Agam Corporate Authors(s) : National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. Poxvirus and Rabies Branch. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting Monkeypox informational session URL : https://stacks.cdc.gov/view/cdc/118597 Rao, Agam (2022). Situational awareness : Monkeypox outbreak—United States, June 2022. 202208(81001). Rao, Agam "Situational awareness : Monkeypox outbreak—United States, June 2022" 202208, no. 81001 (2022) Rao, Agam "Situational awareness : Monkeypox outbreak—United States, June 2022" vol. 202208, no. 81001, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 1.86 MB] Personal Author: Rao, Agam June 23, 2022 | ACIP meeting Monkeypox informational session Description: 01-OPX-Rao-508.pdf File Type: [PDF - 1.86 MB] File Type: [PDF - 1.86 MB] RSV virion and vaccine products Cite CITE Title : RSV virion and vaccine products Personal Author(s) : Thornburg, Natalie J. Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.) Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting Respiratory Syncytial Virus (RSV) Vaccine URL : https://stacks.cdc.gov/view/cdc/118592 Thornburg, Natalie J. (2022). RSV virion and vaccine products. 202208(80802). Thornburg, Natalie J. "RSV virion and vaccine products" 202208, no. 80802 (2022) Thornburg, Natalie J. "RSV virion and vaccine products" vol. 202208, no. 80802, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 4.35 MB] Personal Author: Thornburg, Natalie J. June 23, 2022 | ACIP meeting Respiratory Syncytial Virus (RSV) Vaccine Description: 02-RSV-Thornburg-508.pdf File Type: [PDF - 4.35 MB] File Type: [PDF - 4.35 MB] Updates to the evidence to recommendation framework : use of 15-valent pneumococcal conjugate vaccine in children Cite CITE Title : Updates to the evidence to recommendation framework : use of 15-valent pneumococcal conjugate vaccine in children Personal Author(s) : Kobayashi, Miwako Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. Pneumococcal Vaccines Work Group.;National Center for Immunization and Respiratory Diseases (U.S.); Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 22, 2022 Series : ACIP meeting Pneumococcal Vaccines URL : https://stacks.cdc.gov/view/cdc/118575 Kobayashi, Miwako (2022). Updates to the evidence to recommendation framework : use of 15-valent pneumococcal conjugate vaccine in children. 202208(80204). Kobayashi, Miwako "Updates to the evidence to recommendation framework : use of 15-valent pneumococcal conjugate vaccine in children" 202208, no. 80204 (2022) Kobayashi, Miwako "Updates to the evidence to recommendation framework : use of 15-valent pneumococcal conjugate vaccine in children" vol. 202208, no. 80204, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 495.36 KB] Personal Author: Kobayashi, Miwako June 22, 2022 | ACIP meeting Pneumococcal Vaccines Description: 04-Pneumococcal-Kobayashi-508.pdf File Type: [PDF - 495.36 KB] File Type: [PDF - 495.36 KB] Influenza vaccines for persons aged ≥65 years : evidence to recommendations (EtR) framework Cite CITE Title : Influenza vaccines for persons aged ≥65 years : evidence to recommendations (EtR) framework Personal Author(s) : Grohskopf, Lisa A. Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.) Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 22, 2022 Series : ACIP meeting Influenza URL : https://stacks.cdc.gov/view/cdc/118570 Grohskopf, Lisa A. (2022). Influenza vaccines for persons aged ≥65 years : evidence to recommendations (EtR) framework. 202208(80103). Grohskopf, Lisa A. "Influenza vaccines for persons aged ≥65 years : evidence to recommendations (EtR) framework" 202208, no. 80103 (2022) Grohskopf, Lisa A. "Influenza vaccines for persons aged ≥65 years : evidence to recommendations (EtR) framework" vol. 202208, no. 80103, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 330.20 KB] Personal Author: Grohskopf, Lisa A. June 22, 2022 | ACIP meeting Influenza Description: 03-influenza-grohskopf-508.pdf File Type: [PDF - 330.20 KB] File Type: [PDF - 330.20 KB] V114 Ph-3 pediatric clinical development program update for the ACIP Cite CITE Title : V114 Ph-3 pediatric clinical development program update for the ACIP Personal Author(s) : Banniettis, Natalie Corporate Authors(s) : Merck Research Laboratories. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 22, 2022 Series : ACIP meeting Pneumococcal Vaccines URL : https://stacks.cdc.gov/view/cdc/118573 Banniettis, Natalie (2022). V114 Ph-3 pediatric clinical development program update for the ACIP. 202208(80202). Banniettis, Natalie "V114 Ph-3 pediatric clinical development program update for the ACIP" 202208, no. 80202 (2022) Banniettis, Natalie "V114 Ph-3 pediatric clinical development program update for the ACIP" vol. 202208, no. 80202, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 305.25 KB] Personal Author: Banniettis, Natalie June 22, 2022 | ACIP meeting Pneumococcal Vaccines Description: 02-Pneumo-Banniettis-508.pdf File Type: [PDF - 305.25 KB] File Type: [PDF - 305.25 KB] Preliminary estimates of 2021–22 seasonal influenza vaccine effectiveness against medically attended influenza for the US Flu VE Network Cite CITE Title : Preliminary estimates of 2021–22 seasonal influenza vaccine effectiveness against medically attended influenza for the US Flu VE Network Personal Author(s) : Chung, Jessie R. Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). US Flu VE Network.;National Center for Immunization and Respiratory Diseases (U.S.); Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 22, 2022 Series : ACIP meeting Influenza URL : https://stacks.cdc.gov/view/cdc/118569 Chung, Jessie R. (2022). Preliminary estimates of 2021–22 seasonal influenza vaccine effectiveness against medically attended influenza for the US Flu VE Network. 202208(80102). Chung, Jessie R. "Preliminary estimates of 2021–22 seasonal influenza vaccine effectiveness against medically attended influenza for the US Flu VE Network" 202208, no. 80102 (2022) Chung, Jessie R. "Preliminary estimates of 2021–22 seasonal influenza vaccine effectiveness against medically attended influenza for the US Flu VE Network" vol. 202208, no. 80102, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 384.07 KB] Personal Author: Chung, Jessie R. June 22, 2022 | ACIP meeting Influenza Description: 02-influenza-Chung-508.pdf File Type: [PDF - 384.07 KB] File Type: [PDF - 384.07 KB] Economic analysis and public health impact of PCV15 use among children in the US Cite CITE Title : Economic analysis and public health impact of PCV15 use among children in the US Personal Author(s) : Leidner, Andrew J. Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 22, 2022 Series : ACIP meeting Pneumococcal Vaccines URL : https://stacks.cdc.gov/view/cdc/118574 Leidner, Andrew J. (2022). Economic analysis and public health impact of PCV15 use among children in the US. 202208(80203). Leidner, Andrew J. "Economic analysis and public health impact of PCV15 use among children in the US" 202208, no. 80203 (2022) Leidner, Andrew J. "Economic analysis and public health impact of PCV15 use among children in the US" vol. 202208, no. 80203, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 81.63 KB] Personal Author: Leidner, Andrew J. June 22, 2022 | ACIP meeting Pneumococcal Vaccines Description: 03-Pneumo-Leidner-508.pdf File Type: [PDF - 81.63 KB] File Type: [PDF - 81.63 KB] Influenza Work Group : summary and proposed recommendations for the 2022-23 influenza season Cite CITE Title : Influenza Work Group : summary and proposed recommendations for the 2022-23 influenza season Personal Author(s) : Grohskopf, Lisa A. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.;National Center for Immunization and Respiratory Diseases (U.S.); Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 22, 2022 Series : ACIP meeting Influenza URL : https://stacks.cdc.gov/view/cdc/118571 Grohskopf, Lisa A. (2022). Influenza Work Group : summary and proposed recommendations for the 2022-23 influenza season. 202208(80104). Grohskopf, Lisa A. "Influenza Work Group : summary and proposed recommendations for the 2022-23 influenza season" 202208, no. 80104 (2022) Grohskopf, Lisa A. "Influenza Work Group : summary and proposed recommendations for the 2022-23 influenza season" vol. 202208, no. 80104, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 224.67 KB] Personal Author: Grohskopf, Lisa A. June 22, 2022 | ACIP meeting Influenza Description: 04-influenza-grohskopf-508.pdf File Type: [PDF - 224.67 KB] File Type: [PDF - 224.67 KB] Influenza Work Group : introduction Cite CITE Title : Influenza Work Group : introduction Personal Author(s) : Talbot, H. Keipp Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. Influenza Work Group;National Center for Immunization and Respiratory Diseases (U.S.); Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 22, 2022 Series : ACIP meeting Influenza URL : https://stacks.cdc.gov/view/cdc/118568 Talbot, H. Keipp (2022). Influenza Work Group : introduction. 202208(80101). Talbot, H. Keipp "Influenza Work Group : introduction" 202208, no. 80101 (2022) Talbot, H. Keipp "Influenza Work Group : introduction" vol. 202208, no. 80101, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 121.24 KB] Personal Author: Talbot, H. Keipp June 22, 2022 | ACIP meeting Influenza Description: 01-influenza-talbot-508.pdf File Type: [PDF - 121.24 KB] File Type: [PDF - 121.24 KB] Evidence to Recommendation Framework : Moderna COVID-19 vaccine in children ages 6 – 11 years and adolescents ages 12 – 17 years Cite CITE Title : Evidence to Recommendation Framework : Moderna COVID-19 vaccine in children ages 6 – 11 years and adolescents ages 12 – 17 years Personal Author(s) : Oliver, Sara E. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/118588 Oliver, Sara E. (2022). Evidence to Recommendation Framework : Moderna COVID-19 vaccine in children ages 6 – 11 years and adolescents ages 12 – 17 years. 202208(80606). Oliver, Sara E. "Evidence to Recommendation Framework : Moderna COVID-19 vaccine in children ages 6 – 11 years and adolescents ages 12 – 17 years" 202208, no. 80606 (2022) Oliver, Sara E. "Evidence to Recommendation Framework : Moderna COVID-19 vaccine in children ages 6 – 11 years and adolescents ages 12 – 17 years" vol. 202208, no. 80606, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 7.14 MB] Personal Author: Oliver, Sara E. June 23, 2022 | ACIP meeting COVID-19 Vaccines Description: /06-COVID-Oliver-508.pdf File Type: [PDF - 7.14 MB] File Type: [PDF - 7.14 MB] Update on myocarditis following mRNA COVID-19 vaccination Cite CITE Title : Update on myocarditis following mRNA COVID-19 vaccination Personal Author(s) : Shimabukuro, Tom T. Corporate Authors(s) : CDC COVID-19 Vaccine Coordination Unit. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/118585 Shimabukuro, Tom T. (2022). Update on myocarditis following mRNA COVID-19 vaccination. 202208(80603). Shimabukuro, Tom T. "Update on myocarditis following mRNA COVID-19 vaccination" 202208, no. 80603 (2022) Shimabukuro, Tom T. "Update on myocarditis following mRNA COVID-19 vaccination" vol. 202208, no. 80603, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 2.10 MB] Personal Author: Shimabukuro, Tom T. June 23, 2022 | ACIP meeting COVID-19 Vaccines Description: 03-COVID-Shimabukuro-508.pdf File Type: [PDF - 2.10 MB] File Type: [PDF - 2.10 MB] Burden, prevalence, and trends of long-term sequelae of SARS-CoV-2 Cite CITE Title : Burden, prevalence, and trends of long-term sequelae of SARS-CoV-2 Personal Author(s) : Saydah, Sharon Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.) Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/118584 Saydah, Sharon (2022). Burden, prevalence, and trends of long-term sequelae of SARS-CoV-2. 202208(80602). Saydah, Sharon "Burden, prevalence, and trends of long-term sequelae of SARS-CoV-2" 202208, no. 80602 (2022) Saydah, Sharon "Burden, prevalence, and trends of long-term sequelae of SARS-CoV-2" vol. 202208, no. 80602, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 2.00 MB] Personal Author: Saydah, Sharon June 23, 2022 | ACIP meeting COVID-19 Vaccines Description: 02-COVID-Briggs-Hagan-508.pdf File Type: [PDF - 2.00 MB] File Type: [PDF - 2.00 MB] COVID-19 Vaccine Safety Technical (VaST) Work Group : VaST assessment Cite CITE Title : COVID-19 Vaccine Safety Technical (VaST) Work Group : VaST assessment Personal Author(s) : Talbot, H. Keipp;Hopkins, Robert H.; Corporate Authors(s) : COVID-19 Vaccine Safety Technical (VaST) Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/118586 Talbot, H. Keipp and Hopkins, Robert H. (2022). COVID-19 Vaccine Safety Technical (VaST) Work Group : VaST assessment. 202208(80604). Talbot, H. Keipp and Hopkins, Robert H. "COVID-19 Vaccine Safety Technical (VaST) Work Group : VaST assessment" 202208, no. 80604 (2022) Talbot, H. Keipp and Hopkins, Robert H. "COVID-19 Vaccine Safety Technical (VaST) Work Group : VaST assessment" vol. 202208, no. 80604, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 437.60 KB] Personal Author: Talbot, H. Keipp ; Hopkins, Robert H. June 23, 2022 | ACIP meeting COVID-19 Vaccines Description: 04-COVID-Talbot-508.pdf File Type: [PDF - 437.60 KB] File Type: [PDF - 437.60 KB] Interim clinical considerations update : Moderna COVID-19 vaccine for children ages 6−17 Cite CITE Title : Interim clinical considerations update : Moderna COVID-19 vaccine for children ages 6−17 Personal Author(s) : Hall, Elisha Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/118589 Hall, Elisha (2022). Interim clinical considerations update : Moderna COVID-19 vaccine for children ages 6−17. 202208(80607). Hall, Elisha "Interim clinical considerations update : Moderna COVID-19 vaccine for children ages 6−17" 202208, no. 80607 (2022) Hall, Elisha "Interim clinical considerations update : Moderna COVID-19 vaccine for children ages 6−17" vol. 202208, no. 80607, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 3.14 MB] Personal Author: Hall, Elisha June 23, 2022 | ACIP meeting COVID-19 Vaccines Description: 07-COVID-Hall-508.pdf File Type: [PDF - 3.14 MB] File Type: [PDF - 3.14 MB] ACIP COVID-19 Vaccines Work Group : June 23, 2022 Cite CITE Title : ACIP COVID-19 Vaccines Work Group : June 23, 2022 Personal Author(s) : Daley, Matthew F. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/118583 Daley, Matthew F. (2022). ACIP COVID-19 Vaccines Work Group : June 23, 2022. 202208(80601). Daley, Matthew F. "ACIP COVID-19 Vaccines Work Group : June 23, 2022" 202208, no. 80601 (2022) Daley, Matthew F. "ACIP COVID-19 Vaccines Work Group : June 23, 2022" vol. 202208, no. 80601, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 1.75 MB] Personal Author: Daley, Matthew F. June 23, 2022 | ACIP meeting COVID-19 Vaccines Description: 01-COVID-Daley-508.pdf File Type: [PDF - 1.75 MB] File Type: [PDF - 1.75 MB] Introduction to ACIP’s Adult Respiratory Syncytial Virus Work Group Cite CITE Title : Introduction to ACIP’s Adult Respiratory Syncytial Virus Work Group Personal Author(s) : Kotton, Camille Nelson Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. Adult Respiratory Syncytial Virus Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting Respiratory Syncytial Virus (RSV) Vaccine URL : https://stacks.cdc.gov/view/cdc/118591 Kotton, Camille Nelson (2022). Introduction to ACIP’s Adult Respiratory Syncytial Virus Work Group. 202208(80801). Kotton, Camille Nelson "Introduction to ACIP’s Adult Respiratory Syncytial Virus Work Group" 202208, no. 80801 (2022) Kotton, Camille Nelson "Introduction to ACIP’s Adult Respiratory Syncytial Virus Work Group" vol. 202208, no. 80801, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 400.81 KB] Personal Author: Kotton, Camille Nelson June 23, 2022 | ACIP meeting Respiratory Syncytial Virus (RSV) Vaccine Description: 01-RSV-Kotton-508.pdf File Type: [PDF - 400.81 KB] File Type: [PDF - 400.81 KB] Priorix for prevention of Measles, Mumps, and Rubella Cite CITE Title : Priorix for prevention of Measles, Mumps, and Rubella Personal Author(s) : Krow-Lucal, Elisabeth R. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. Measles, Mumps, and Rubella (MMR) Vaccine Work Group.;National Center for Immunization and Respiratory Diseases (U.S.); Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 22, 2022 Series : ACIP meeting Mumps URL : https://stacks.cdc.gov/view/cdc/118578 Krow-Lucal, Elisabeth R. (2022). Priorix for prevention of Measles, Mumps, and Rubella. 202208(80402). Krow-Lucal, Elisabeth R. "Priorix for prevention of Measles, Mumps, and Rubella" 202208, no. 80402 (2022) Krow-Lucal, Elisabeth R. "Priorix for prevention of Measles, Mumps, and Rubella" vol. 202208, no. 80402, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 812.56 KB] Personal Author: Krow-Lucal, Elisabeth R. June 22, 2022 | ACIP meeting Mumps Description: 02-MMR-Krow-Lucal-508.pdf File Type: [PDF - 812.56 KB] File Type: [PDF - 812.56 KB]

More +